Precision Medicine: Personalized Treatment, Genetic Testing, and ALS Clinical Trials Explained

Precision medicine and ALS means using a person’s unique biology to guide care and research in ALS, MND, ALS disease, Amyotrophic lateral sclerosis, Motor Neuron disease, and Lou Gehrig’s disease. If you’re searching what is ALS and wondering why it progresses differently from one person to another, precision medicine helps explain those differences. ALS symptoms may include muscle weakness, difficulty speaking or swallowing (including Bulbar ALS), and breathing changes. The Early signs of ALS and the speed of change across ALS stages can vary widely. Precision medicine looks at what may be driving ALS in each individual—genes, protein buildup, inflammation, or other biological signals—and uses that information to guide ALS diagnosis, monitoring, and research decisions. A common question is: Is ALS genetic? About 10% of cases are Familial ALS, linked to specific gene changes such as SOD1 or C9orf72. In these cases, genetic testing can help determine eligibility for targeted ALS clinical trials. For people with sporadic ALS, researchers use biomarkers, such as neurofilament light in blood or spinal fluid, to better understand disease activity and measure how well an ALS treatment is working. Related searches often include: personalized ALS treatment, genetic testing for ALS, ALS biomarkers, targeted therapy for ALS, and ALS clinical trials near me. People also ask: What are ALS causes? and Can precision medicine improve ALS life expectancy or How long do you live with ALS? While there is no ALS cure, precision medicine may improve how we estimate ALS prognosis and connect individuals to the most appropriate studies and supportive care sooner. This video is for people newly diagnosed, patients, care partners, professional caregivers, medical professionals, and the broader ALS community—including friends and family seeking clear, accessible answers.